Aravive, Inc.
ARAVDelisted Jan 29, 2024- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001513818
Aravive, Inc. was delisted on Jan 29, 2024; its insiders filed their last Form 4 on Apr 11, 2023; 30 institutions reported holding it in 13F filings for Q4 2023, worth $825.5K in total; no superinvestor held it.
Q4 2023 vs. Q3 2023
How the institutions holding Aravive, Inc. changed between Q3 2023 and Q4 2023.
All holders in Q4 2023All holders in Q3 2023
| Measure | Q3 2023 | Q4 2023 | Change |
|---|---|---|---|
| Holders | 33 | 30 | −3 |
| Shares | 5.98M | 6.70M | +714.4K (+11.9%) |
| Value | $786.9K | $825.5K | +$38.6K (+4.9%) |
New holders (3)
Institutions that held Aravive, Inc. at the end of Q4 2023 but not at the end of Q3 2023.
| Institution | Shares | Value | % of portfolio |
|---|---|---|---|
| Gsa Capital Partners LLP | 1,977,407 | $245.0K | 0.02% |
| Collective Family Office LLC | 15,000 | $1.86K | 0.00% |
| Jane Street Group, LLC | 12,904 | $1.60K | 0.00% |
Sold out (6)
Institutions that held Aravive, Inc. at the end of Q3 2023 and filed for Q4 2023 without it.
| Institution | Shares, Q3 2023 | Value, Q3 2023 |
|---|---|---|
| Millennium Management LLC | 395,797 | $52.2K |
| Prudential Financial Inc | 259,800 | $34.3K |
| XTX Topco Ltd | 16,009 | $2.11K |
| StoneX Group Inc. | 12,531 | $1.65K |
| National Bank of Canada | 100 | $13 |
| CWM, LLC | 16 | $0 |